Niacin use was associated with a 34% reduction in cardiovascular events which was defined as cardiac death, nonfatal myocardial infarction, hospitalization for acute coronary syndrome, stroke, or revascularization procedure according to a review of 11 trials including 9,956 subjects done by researchers at Tufts Medical Center in Boston, Massachusetts, USA.
“The consensus perspective derived from available clinical data supports that niacin reduces [cardiovascular disease] events,” the paper concluded.
Unfortunately, only one study gave niacin alone. The other 10 of the 11 studies gave niacin plus a statin or other cholesterol-lowering drug.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.